The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
121459363 12145936 3 F 20150305 20160629 20160304 20160707 EXP JP-GILEAD-2016-0201622 GILEAD 26.00 YR A F Y 49.30000 KG 20160707 CN JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
121459363 12145936 1 PS AMBRISENTAN AMBRISENTAN 1 Oral 5 MG, QD 50 MG 22081 5 MG TABLET QD
121459363 12145936 2 SS AMBRISENTAN AMBRISENTAN 1 Oral 10 MG, QD 50 MG 22081 10 MG TABLET QD
121459363 12145936 3 SS FLOLAN EPOPROSTENOL SODIUM 1 Intravenous (not otherwise specified) 2-40 NG/KG/MIN 0
121459363 12145936 4 SS FLOLAN EPOPROSTENOL SODIUM 1 0
121459363 12145936 5 C ADCIRCA TADALAFIL 1 UNK 0
121459363 12145936 6 C ADCIRCA TADALAFIL 1 UNK 0
121459363 12145936 7 C FUROSEMIDE. FUROSEMIDE 1 UNK 0
121459363 12145936 8 C COCARL ACETAMINOPHEN 1 UNK 0
121459363 12145936 9 C SLOW-K POTASSIUM CHLORIDE 1 UNK 0
121459363 12145936 10 C CARBOCISTEINE CARBOCYSTEINE 1 UNK 0
121459363 12145936 11 C BIOFERMIN R BACILLUS SUBTILISLACTOBACILLUS ACIDOPHILUSSTREPTOCOCCUS FAECAIS 1 UNK 0
121459363 12145936 12 C MYSLEE ZOLPIDEM TARTRATE 1 UNK 0
121459363 12145936 13 C CARBOCISTEINE TABLETS 2 UNK 0
121459363 12145936 14 C BIOFERMIN R (JAPAN) 2 UNK 0
121459363 12145936 15 C ACUATIM NADIFLOXACIN 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
121459363 12145936 1 Pulmonary arterial hypertension
121459363 12145936 2 Pulmonary arterial hypertension
121459363 12145936 4 Pulmonary arterial hypertension
121459363 12145936 5 Pulmonary arterial hypertension
121459363 12145936 9 Prophylaxis
121459363 12145936 10 Gastritis prophylaxis
121459363 12145936 11 Prophylaxis against diarrhoea
121459363 12145936 12 Prophylaxis
121459363 12145936 13 Prophylaxis
121459363 12145936 14 Prophylaxis against diarrhoea

Outcome of event

Event ID CASEID OUTC COD
121459363 12145936 OT
121459363 12145936 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
121459363 12145936 Acute respiratory distress syndrome
121459363 12145936 Device breakage
121459363 12145936 Headache
121459363 12145936 Pain in extremity
121459363 12145936 Pneumonia
121459363 12145936 Pruritus

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
121459363 12145936 1 20150223 20150512 0
121459363 12145936 2 20150513 0
121459363 12145936 3 20150227 0
121459363 12145936 6 20150218 0
121459363 12145936 7 20150218 0
121459363 12145936 8 20150513 0
121459363 12145936 9 20150320 0
121459363 12145936 10 20150311 0
121459363 12145936 11 20150308 0
121459363 12145936 12 20150323 0
121459363 12145936 13 20150311 0
121459363 12145936 14 20150308 0